INSIGHTS ON QUALITY CONTROL
-
0.45 m/s ±20% At Working Position In Closed Sterility Testing Isolators: Requirement Or Convention?
Balance compliance and efficiency in sterility testing. Explore how a risk-based approach to airflow and isolator technology aligns with Annex 1 while optimizing contamination control.
-
Building A Culture Of GxP Excellence In 2026—Veeva Training Solutions Podcast
Shift from basic compliance to a strategic GxP culture. Explore how intentional, role-specific training and leadership support reduce risks and improve business outcomes in this video.
-
Maintaining A State Of Control: EM And DES In Biopharma
Partner with a proven team to streamline your facility validation and environmental monitoring programs with flexible, cGMP-compliant services and reliable on-site collection.
-
Biocatalysis 101: Faster, Greener API Manufacturing
View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.
-
Development To Large-Scale cGMP Production7/25/2024
For manufacturers working with a dry powder medium (DPM), early consultation with a supplier can increase the likelihood of success. Uncover a two-phase scale-up strategy for the production of DPM.
-
Understanding cGMPs For Phase 1 Investigational Drugs8/15/2025
Learn how a structured, risk-based approach to early-phase manufacturing can help streamline processes, reduce costs, and accelerate the path to first-in-human trials while meeting FDA cGMP guidelines.
-
Aseptic Filling Quality Through Precision3/20/2026
Precise measurement shapes every reliable workcell. Meet Andrew, a specialist who verifies components with micron‑level accuracy, ensuring each piece is built to perform exactly as designed.
-
Ensuring Compliance For Virtual And Hybrid Pharmaceutical Companies10/16/2025
Proactive, risk-based oversight must be established to manage outsourced GXP activities. This requires a robust QMS and comprehensive quality agreements to safeguard product quality and data integrity.
-
Tackling Residual DNA Testing In Biotherapy Manufacturing7/16/2025
Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.
QUALITY CONTROL SOLUTIONS
-
Blue Mountain Regulatory Asset Manager (RAM) helps life sciences manufacturers standardize maintenance, calibration, and asset workflows across sites in one validated platform.
-
The Powder Rheology Accessory expands the DHR’s capabilities to powders, enabling the characterization of behaviors during storage, dispensing, processing, and end-use.
-
Advance biologic and bioconjugate programs with unified platforms, scalable GMP manufacturing, and specialized capabilities that move teams efficiently from early design to clinical readiness.
-
One (1) used Elizabeth Hata Elizatest Auto Sampler, model 3+, with (8) sample stations, with Mettler-Toledo scale, disposal bin, serial # ET3089707007
-
Performing endotoxin testing? Trust your data with a Monocyte Activation Test that mimics the human immune reaction and detects both endotoxins and non-endotoxin pyrogens.